Gro for Tissue Therapies
Wednesday, 09 July, 2008
Tissue Therapies [ASX: TIS] is to conduct a clinical trial of its VitroGro wound healing technology in Perth, to begin in August.
The trial will be conducted at UWA Professor Chris Stacey's wound care clinic in Perth, and will concentrate on venous ulcers.
Tissue Therapies is also awaiting regulatory approval to conduct another group of trials in Toronto, Canada, which will concentrate on diabetic and pressure ulcers (bed sores). Preparation for both trials is complete.
VitroGro has already undergone more than six years of laboratory research using live human skin cells. The technology was developed from research at Queensland University of Technology's Institute for Health and Biomedical Innovation (IHBI).
Hormone therapy shifts body proteins to match gender identity
Researchers have discovered that gender-affirming hormone therapy can alter body proteins to...
Targeting 'molecular bodyguards' weakens prostate cancer cells
Research reveals that two enzymes — PDIA1 and PDIA5 — act as 'molecular...
Females found to carry a higher genetic risk of depression
An international team of scientists has discovered about twice as many genetic 'flags'...
